Corrona, LLC (“Corrona”), a built-for-purpose source of gold-standard real-world evidence, announced that it has acquired HealthUnlocked, the world’s largest virtual patient community.
Corrona’s investment in HealthUnlocked helps to further expand the patient engagement offerings that began in late 2019 with Corrona’s acquisition of HealthiVibe, a recognized leader in patient experience and engagement. HealthUnlocked provides an additional dimension of cultivated data by leveraging a social network of 1.3 million patients across hundreds of condition-specific communities, moderated by over 500 patient advocacy groups, capturing insights to better understand what matters most to these patients. HealthUnlocked will be integrated into Corrona’s HealthiVibe business unit to establish an innovative and holistic snapshot of the patient.
“By combining with HealthUnlocked, we are expanding our broad set of capabilities–ranging from highly granular and longitudinal structured data across our eight registries, to broader patient insights from HealthUnlocked,” said Abbe Steel, Chief Patient Officer of Corrona. She continued, “The HealthUnlocked communities provide access to engaged patients across the globe, allowing us to better understand the patient experience and what matters most to patients. Our organization is positioned to expand its expertise in gathering, analyzing, and applying deep patient insights to optimize the patient journey and bring significant value to our clients.”
Jorge Armanet, CEO of HealthUnlocked, noted “We are thrilled to be joining Corrona to help further expand its patient-centered solutions. Over the past 10 years, we have created a robust real-world data engine with the patient at its core. Patients that engage in our communities offer a unique perspective, creating not only a truly powerful resource for the research industry, but also invaluable peer-to-peer support. This support allows millions of patients globally to become more confident, and to interact more easily with healthcare professionals.”
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
By building out its patient experience business, Corrona is working to create an industry-leading ecosystem centered around the patient voice. This ecosystem directly supports both the 21st Century Cures Act and the FDA’s Patient Focused Drug Development initiative, and establishes Corrona as a leader in patient insights and real-world evidence with both a scalable technology platform, and short- and long-term outcomes and safety data. This data powerhouse is the first of its kind to provide such a wholistic, 360⁰ degree view of a patient while ensuring data integrity.
Source: Biospace